While many people were surprised at Donald Trump’s victory over Hillary Clinton in the U.S. Presidential race, the impact was substantial in terms of pharmaceutical stocks, which reportedly surged in Europe on Wednesday. According to Fortune, Trump’s victory led investors to believe the threat of tough action against pricing of pharmaceutical drugs had subsided. News reports indicate that, following the …
REA JET To Exhibit At Fabtech 2016 Beginning November 16
Beginning November 16, REA JET will be exhibiting at Fabtech 2016, held at the Las Vegas Convention Center, and we’re excited! Fabtech 2016 is where those in the metal industry can “sharpen their edge” about all things metal forming, welding, fabricating, and finishing. Enjoy the exhibits, network with others in the industry, see the latest innovations, and increase your knowledge! …
Will Pharma Expo 2016 And Pack Expo Break Attendee Records?
As Pharma Expo 2016 & Pack Expo grows nearer, show producer PMMI predicts it will be the largest ever, and even a record breaker with projections that some 50,000 attendees will be present over the course of the show. No doubt that with more than 1.2 million net square feet of exhibit space and 2,500+ exhibitors, including REA JET, those …
Attending Pharma EXPO 2016? What To Expect
REA JET will exhibit at Pharma EXPO 2016 in Chicago next month, so we’re excited to share with those who plan to attend what you can expect regarding trends in the pharmaceutical industry. Some of the hurdles addressed include drug counterfeiting, user-friendly packaging, reduced expenses and waste, accuracy-enhancing dosing, and increasing patient safety and efficiency, according to a press release. …
Pharma Marking – First Marijuana-Based Therapy Approved In U.S.?
Recently it was announced that Epidiolex, a marijuana-based therapy that received impressive clinical trial results for experimental therapy in those with LGS (Lenox-Gastaut Syndrome), could be the first marijuana-based drug in the U.S. if GW Pharmaceuticals wins regulatory clearance. Trial results sent GW’s stock soaring with shares closing at $126.06. The pharmaceutical company’s results help set the stage for application …